PROGESTERONE ANALOGS TO REVERSE MULTIDRUG RESISTANCE
    1.
    发明申请
    PROGESTERONE ANALOGS TO REVERSE MULTIDRUG RESISTANCE 审中-公开
    PROGESTERONE模拟反转多重耐药性

    公开(公告)号:WO1997000683A1

    公开(公告)日:1997-01-09

    申请号:PCT/US1996010751

    申请日:1996-06-24

    CPC classification number: C07J41/005

    Abstract: The present invention is directed to novel progesterone derivatives, as well as to pharmaceutical compositions thereof, and methods of treatment using the derivatives. More particularly, the invention relates to C7-substituted derivatives of the pregnene series. The present invention is directed to methods of treating multidrug-resistant tumors, and especially breast tumors, with novel C7-substituted progesterone analogs.

    Abstract translation: 本发明涉及新颖的孕酮衍生物及其药物组合物,以及使用衍生物的治疗方法。 更具体地,本发明涉及孕烯系列的C7-取代的衍生物。 本发明涉及用新型C7-取代的孕酮类似物治疗多药耐药性肿瘤,特别是乳腺肿瘤的方法。

    PROGESTERONE ANALOGS TO REVERSE MULTIDRUG RESISTANCE
    2.
    发明公开
    PROGESTERONE ANALOGS TO REVERSE MULTIDRUG RESISTANCE 失效
    孕激素类似物克服多药耐药性

    公开(公告)号:EP0859618A1

    公开(公告)日:1998-08-26

    申请号:EP96922550.0

    申请日:1996-06-24

    CPC classification number: C07J41/005

    Abstract: The present invention is directed to novel progesterone derivatives, as well as to pharmaceutical compositions thereof, and methods of treatment using the derivatives. More particularly, the invention relates to C7-substituted derivatives of the pregnene series. The present invention is directed to methods of treating multidrug-resistant tumors, and especially breast tumors, with novel C7-substituted progesterone analogs.

Patent Agency Ranking